Perspective Therapeutics Shares Are Trading Lower. The Company Announced Initial Results From Its Ongoing Phase 1/2a Clinical Trial of [212Pb]VMT-α-NET.
Perspective Therapeutics Shares Are Trading Lower. The Company Announced Initial Results From Its Ongoing Phase 1/2a Clinical Trial of [212Pb]VMT-α-NET.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.